Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 8897 - 8904 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCN7920 | Physalin A |
|
1. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
2. Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-κB survival pathway in A375-S2 cells. 3. Physalin A inhibits androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor expression. |
|
| BCN7921 | Physalin B |
|
1. Physalin B shows potent anti-Trypanosoma cruzi activity.
2. Physalin B shows antimalarial activity. 3. Physalin B can inhibit the growth of several human leukemia cells. 4. Physalin B has the potential to be developed as an effective chemotherapeutic lead compound for the treatment of malignant melanoma. 5. Physalin B inhibits Rhodnius prolixus hemocyte phagocytosis and microaggregation by the activation of endogenous PAF-acetyl hydrolase activities. 6. Physalin B exhibits a minimum inhibitory concentration value (MIC) against Mycobacterium tuberculosis H(37)Rv strain of 32 microg/mL. 7. Physalin B inhibits androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor expression. 8. Physalin B presents antinociceptive properties associated with central. |
|
| BCN7924 | Mogroside IIIe |
|
1. Mogroside IIIe has anti-inflammatory activity, it attenuates LPS-induced acute lung injury in mice partly through regulation of the TLR4/MAPK/NF-κB axis via AMPK activation.
2. Mogroside IIIe has anti-fibrotic activity, it reduces pulmonary fibrosis through Toll-Like receptor 4 pathways. |
|
| BCN7925 | Mogroside III-A2 |
|
1. Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
|
|
| BCN7926 | Mogroside II-A1 |
|
1. Mogroside II-A1 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
|
|
| BCN7927 | Trilobinine |
|
1. (+)-Trilobinine has relaxant effects via the activation of beta 2-adrenoceptors, it can reduce the spontaneous tone and inhibit the contractions induced by carbachol and histamine.
|
|
| BCN7928 | Caulophyllumine A |
|
Caulophyllumine A is a natural product from Cimicifuga heracleifolia.
|
|
| BCN7929 | 5-O-Caffeoylshikimic acid |
|
1. 5-O-Caffeoylshikimic acid shows moderate MDR reversal activity.
2. 5-O-Caffeoylshikimic acid shows anti-oxidative activity . 3. 5-O-Caffeoylshikimic acid can remarkably inhibit the macrophage migration and adhesion. 4. 5-O-Caffeoylshikimic acid has anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB. |
|